Heidi Wissmiller
Known title: DirectorCIK: 0001821126
Associated companies
Transaction History
| NATR | ▲ Buy | Grant | 4,500 | $0 | 5/15/2026 | View on chart |
| NATR | ▲ Buy | Grant | 8,000 | $0 | 5/5/2025 | View on chart |
| NATR | ▲ Buy | Grant | 5,236 | $100K | 5/6/2024 | View on chart |
| NATR | ▲ Buy | Grant | 9,355 | $0 | 5/3/2023 | View on chart |
| NATR | ▲ Buy | Grant | 6,181 | $0 | 5/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.